Highlights Affymax, Inc.

Stocks

AFFY

US00826A1097

Biotechnology & Medical Research

Delayed OTC Markets Other stock markets 18:33:36 08/06/2026 +04			5-day change	1st Jan Change
0.001000 ^USD	-16.67%		-16.67%	+25.00%

27/11/14	Affymax, Inc. Declares Special Cash Distribution, Payable on or About December 23, 2014; Appoints Jonathan M. Couchman as Class I Director, President and Chief Executive Officer	CI
26/11/14	Affymax Seeks Acquisitions	CI

Highlights

26/11/14	Affymax Seeks Acquisitions	CI
01/08/14	Affymax, Inc. Announces Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended June 30, 2014	CI
16/06/14	Affymax Terminates Omontys' Product Collaboration and License Agreement with Takeda Pharmaceutical Company, Effective September 10, 2014	CI
14/06/14	Affymax and Takeda Announce Termination of Omontys(R) (peginesatide) Product Collaboration and License Agreement	CI
21/08/13	Affymax, Inc. Executes a Seventh Amendment to Lease Agreement	CI
02/04/13	Affymax, Inc. Announces Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2012	CI
25/02/13	Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of OMONTYS® (peginesatide) Injection	CI
24/01/13	Affymax, Inc. and Takeda Pharmaceuticals Announces Pivotal Phase 3 Data on the Safety and Efficacy of OMONTYS(R) (peginesatide) Injection	CI
09/11/12	Affymax, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2012; Provides Financial Guidance for 2012	CI
02/11/12	Affymax, Inc. and Takeda Pharmaceuticals U.S.A., Inc. Announces Analyze from OMONTYS(R) (Peginesatide) Injection Phase 3 Dialysis Studies	CI
09/08/12	Affymax, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2012	CI
09/08/12	Takeda Pharmaceuticals U.S.A., Inc. and Affymax Announce Supply Agreement for OMONTYS (peginesatide) Injection with U.S. Renal Care	CI
12/07/12	Takeda Pharmaceuticals U.S.A., Inc. and Affymax, Inc. Announce Supply Agreement for OMONTYS (Peginesatide) Injection with Fresenius Medical Care North America	CI
08/05/12	Affymax, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2012	CI
15/03/12	Affymax, Inc. Reports Earnings Results for the Full Year Ended December 31, 2011	CI
27/02/12	Affymax, Inc. Enters into a Co-Promotion Agreement with Takeda Pharmaceuticals	CI

No results match your criteria

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!